Yoshiaki Tokano

Soluble Fas (APO‐1, CD95) and soluble Fas ligand in rheumatic diseases

Kazuhisa Nozawa, Nobuhiko Kayagaki, Yoshiaki Tokano et al. · Arthritis & Rheumatism · 1997 · 144 citations

Medicine, Immunology, Internal Medicine +17

Levels of IL-12 in the sera of patients with systemic lupus erythematosus (SLE)—relation to Th1- and Th2-derived cytokines

Yoshiaki Tokano, Shinji Morimoto, Hiroyuki Kaneko et al. · Clinical & Experimental Immunology · 1999 · 139 citations · Full text

Life Sciences, Immunology, Autoimmunity +11

Accuracy of cerebrospinal fluid IL-6 testing for diagnosis of lupus psychosis. A multicenter retrospective study

Shunsei Hirohata, Yoshinori Kanai, Akiko Mitsuo et al. · Clinical Rheumatology · 2009 · 118 citations

Life Sciences, Immunology, Internal Medicine +16

CD134L Engagement Enhances Human B Cell Ig Production: CD154/CD40, CD70/CD27, and CD134/CD134L Interactions Coordinately Regulate T Cell-Dependent B Cell Responses

Shinji Morimoto, Yumiko Kanno, Yuetsu Tanaka et al. · The Journal of Immunology · 2000 · 78 citations · Full text

Life Sciences, Cell Biology, Immunology +14

Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production

Shinji Morimoto, Souichiro Nakano, Takashi Watanabe et al. · Lara D. Veeken · 2007 · 76 citations

Life Sciences, Immunology, Molecular Biology +17